Katrin Fantur

发表

A fluorescent probe for GM1 gangliosidosis related β-galactosidase: N-(dansylamino)hexylaminocarbonylpentyl-1,5-dideoxy-1,5-imino-D-galactitol.

S. Withers, R. Furneaux, Richard F. G. Fröhlich, 2011, Bioorganic & medicinal chemistry letters.

Synthesis of lipophilic 1-deoxygalactonojirimycin derivatives as D-galactosidase inhibitors

S. Withers, G. Schitter, T. Wrodnigg, 2010, Beilstein journal of organic chemistry.

Fluorous iminoalditols act as effective pharmacological chaperones against gene products from GLB1 alleles causing GM1-gangliosidosis and Morquio B disease

T. Wrodnigg, Bettina M. Pabst, E. Paschke, 2012, Journal of Inherited Metabolic Disease.

Fluorous Iminoalditols: A New Family of Glycosidase Inhibitors and Pharmacological Chaperones

S. Withers, G. Schitter, T. Wrodnigg, 2010, Chembiochem : a European journal of chemical biology.

DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human G(M1)-gangliosidosis fibroblasts.

G. Schitter, T. Wrodnigg, Andreas J. Steiner, 2010, Molecular genetics and metabolism.

GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid β‐galactosidase

U. Ramaswami, B. Plecko, C. Caillaud, 2009, Human mutation.

Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations

B. Plecko, A. Vellodi, H. Michelakakis, 2010, Clinical genetics.

The Brakeless co-regulator can directly activate and repress transcription in early Drosophila embryos.

M. Mannervik, Per-Henrik Holmqvist, Filip Crona, 2015, Developmental biology.

1-Deoxygalactonojirimycin-lysine hybrids as potent D-galactosidase inhibitors.

S. Withers, G. Schitter, T. Wrodnigg, 2008, Bioorganic & medicinal chemistry.

GM1 gangliosidosis and Morquio B disease: Expression analysis of missense mutations affecting the catalytic site of acid β-galactosidase

B. Plecko, H. Michelakakis, E. Paschke, 2008 .